Lack of neighborhood effects from a transcriptionally active phosphoglycerate kinase-neo cassette located between the murine beta-major and beta-minor globin genes.

For the treatment of beta-globin gene defects, a homologous recombination-mediated gene correction approach would provide advantages over random integration-based gene therapy strategies. However, "neighborhood effects" from retained selectable marker genes in the targeted locus are among the key issues that must be taken into consideration for any attempt to use this strategy for gene correction. An Ala-to-Ile mutation was created in the beta6 position of the mouse beta-major globin gene (beta(6I)) as a step toward the development of a murine model system that could serve as a platform for therapeutic gene correction studies. The marked beta-major gene can be tracked at the level of DNA, RNA, and protein, allowing investigation of the impact of a retained phosphoglycerate kinase (PGK)-neo cassette located between the mutant beta-major and beta-minor globin genes on expression of these 2 neighboring genes. Although the PGK-neo cassette was expressed at high levels in adult erythroid cells, the abundance of the beta(6I) mRNA was indistinguishable from that of the wild-type counterpart in bone marrow cells. Similarly, the output from the beta-minor globin gene was also normal. Therefore, in this specific location, the retained, transcriptionally active PGK-neo cassette does not disrupt the regulated expression of the adult beta-globin genes. (Blood. 2001;98:65-73)

[1]  S. Bentley,et al.  Gene correction in hematopoietic progenitor cells by homologous recombination. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[2]  Michel Sadelain,et al.  Therapeutic haemoglobin synthesis in β-thalassaemic mice expressing lentivirus-encoded human β-globin , 2000, Nature.

[3]  A. Nienhuis,et al.  Gene therapy for the hemoglobin disorders: past, present, and future. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[4]  T. Ley,et al.  Transgenic analysis of a 100-kb human beta-globin cluster-containing DNA fragment propagated as a bacterial artificial chromosome. , 1999, Blood.

[5]  A. Porter,et al.  Gene targeting is enhanced in human cells overexpressing hRAD51 , 1999, Gene Therapy.

[6]  S. Walker,et al.  Quantitative RT-PCR : Pitfalls and Potential , 1999 .

[7]  T. Ley,et al.  The 5' flanking region of the human granzyme H gene directs expression to T/natural killer cell progenitors and lymphokine-activated killer cells in transgenic mice. , 1999, Blood.

[8]  Y. Kan,et al.  Transgenic knockout mice exclusively expressing human hemoglobin S after transfer of a 240-kb betas-globin yeast artificial chromosome: A mouse model of sickle cell anemia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[9]  M. Groudine,et al.  The Locus Control Region Is Necessary for Gene Expression in the Human β-Globin Locus but Not the Maintenance of an Open Chromatin Structure in Erythroid Cells , 1998, Molecular and Cellular Biology.

[10]  B. Sullenger,et al.  Ribozyme-Mediated Repair of Sickle β-Globin mRNAs in Erythrocyte Precursors , 1998 .

[11]  T. Ley,et al.  Stochastic, stage-specific mechanisms account for the variegation of a human globin transgene. , 1998, Nucleic acids research.

[12]  S. Rivella,et al.  Genetic treatment of severe hemoglobinopathies: the combat against transgene variegation and transgene silencing. , 1998, Seminars in hematology.

[13]  D. Russell,et al.  Human gene targeting by viral vectors , 1998, Nature Genetics.

[14]  R. Kingston,et al.  Disruption of downstream chromatin directed by a transcriptional activator. , 1997, Genes & development.

[15]  E. Rubin,et al.  Transgenic knockout mice with exclusively human sickle hemoglobin and sickle cell disease. , 1997, Science.

[16]  T. Townes,et al.  Knockout-transgenic mouse model of sickle cell disease. , 1997, Science.

[17]  S. Orkin,et al.  A "knockdown" mutation created by cis-element gene targeting reveals the dependence of erythroid cell maturation on the level of transcription factor GATA-1. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[18]  J. Gore,et al.  Magnetic resonance evidence of hypoxia in a homozygous alpha-knockout of a transgenic mouse model for sickle cell disease. , 1996, The Journal of clinical investigation.

[19]  T. Ley,et al.  Long-range disruption of gene expression by a selectable marker cassette. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[20]  M. Rice,et al.  Correction of the Mutation Responsible for Sickle Cell Anemia by an RNA-DNA Oligonucleotide , 1996, Science.

[21]  T. Ley,et al.  Analysis of mice containing a targeted deletion of beta-globin locus control region 5' hypersensitive site 3 , 1996, Molecular and cellular biology.

[22]  B. Wold,et al.  Know Your Neighbors: Three Phenotypes in Null Mutants of the Myogenic bHLH Gene MRF4 , 1996, Cell.

[23]  T. Ley,et al.  Targeted deletion of 5'HS2 of the murine beta-globin LCR reveals that it is not essential for proper regulation of the beta-globin locus. , 1995, Genes & development.

[24]  F. Grosveld,et al.  Generation of a high-titer retroviral vector capable of expressing high levels of the human beta-globin gene. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[25]  J. Baron,et al.  The Molecular Basis of Blood Diseases , 1994 .

[26]  T. Townes,et al.  Retroviral vector sequences inhibit human beta-globin gene expression in transgenic mice. , 1994, Nucleic acids research.

[27]  S. Orkin,et al.  Long-term in vivo expression of a murine adenosine deaminase gene in rhesus monkey hematopoietic cells of multiple lineages after retroviral mediated gene transfer into CD34+ bone marrow cells. , 1993, Blood.

[28]  M. Groudine,et al.  An "in-out" strategy using gene targeting and FLP recombinase for the functional dissection of complex DNA regulatory elements: analysis of the beta-globin locus control region. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[29]  W. Shehee,et al.  Lethal thalassemia after insertional disruption of the mouse major adult beta-globin gene. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[30]  I. Plavec,et al.  A human beta-globin gene fused to the human beta-globin locus control region is expressed at high levels in erythroid cells of mice engrafted with retrovirus-transduced hematopoietic stem cells. , 1993, Blood.

[31]  R. Nagel,et al.  High expression of human beta S- and alpha-globins in transgenic mice: hemoglobin composition and hematological consequences. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[32]  R. Nagel,et al.  High expression of human beta S- and alpha-globins in transgenic mice: erythrocyte abnormalities, organ damage, and the effect of hypoxia. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[33]  M. Doyle,et al.  Regulation of oxygen affinity by quaternary enhancement: Does hemoglobin ypsilanti represent an allosteric intermediate? , 1992, Proteins.

[34]  D. Valerio,et al.  Long-term expression of human adenosine deaminase in rhesus monkeys transplanted with retrovirus-infected bone-marrow cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[35]  W. C. Forrester,et al.  Inactivation of the human beta-globin gene by targeted insertion into the beta-globin locus control region. , 1992, Genes & development.

[36]  H. S. Kim,et al.  Correction of a human beta S-globin gene by gene targeting. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[37]  W. C. Forrester,et al.  High-level beta-globin expression after retroviral transfer of locus activation region-containing human beta-globin gene derivatives into murine erythroleukemia cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[38]  L. Skow,et al.  A mouse model for β-thalassemia , 1983, Cell.

[39]  L. Skow,et al.  A Mouse Model for b-Thalassemia , 1982 .

[40]  B. Alter,et al.  Globin Chain Electrophoresis: a New Approach to the Determination of the Gγ/Aγ Ratio in Fetal Haemoglobin and to Studies of Globin Synthesis , 1980 .

[41]  Arthur W. Nienhuis,et al.  Hemoglobin switching , 1978, Cell.

[42]  S. Gill,et al.  Membrane-covered thin-layer optical cell for gas-reaction studies of hemoglobin. , 1978, Analytical biochemistry.

[43]  R. Nagel,et al.  High expression of human pBs and a-globins in transgenic mice: Hemoglobin composition and hematological consequences , 2022 .

[44]  R. Nagel,et al.  High expression of human 8s- and a-globins in transgenic mice: Erythrocyte abnormalities, organ damage, and the effect of hypoxia , 2022 .